Retracted: Immature Colon Carcinoma Transcript 1 Is Essential for Prostate Cancer Cell Viability and Proliferation

Abstract

Cancer Biotherapy and Radiopharmaceuticals

officially retracts the article entitled, “Immature Colon Carcinoma Transcript 1 Is Essential for Prostate Cancer Cell Viability and Proliferation,” by Zhijun Wang, Danfeng Xu, Yi Gao, Yushan Liu, Jizhong Ren, Yacheng Yao, Lei Yin, Jie Chen, Sishun Gan, and Xingang Cui, (Cancer Biother Radiopharm 2015;30(7):278–284; doi: 10.1089/cbr.2014.1728) due to incorrectly attributed or identified sequences. Several figures and text within the methods section are strikingly similar to those in other publications^1–3 and suggests that same party prepared these papers for entirely different author sets.

The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves.

References

1. Zhang C, Zhang T, Song E, et al. Ribosomal protein S15A augments human osteosarcoma xell proliferation in vitro. Cancer Biother Radiopharm 2018;29(10):451–456; doi: 10.1089/cbr.2014.1698.

2. Wang H, Wang B, Zhu W. et al. Lentivirus-mediated knockdown of myosin VI inhibits cell proliferation of breast cancer cell. Cancer Biother Radiopharm 2015;30(8):330–335; doi: 10.1089/cbr.2014.1759.

3. Zhao S, Chen X, Wan M, et al. Tectonic 1 is a key regulator of cell proliferation in pancreatic cancer. Cancer Biother Radiopharm 2016;31(1):7–13; doi: 10.1089/cbr.2014.1778.